Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

HBI Spotlight

 

European operators brace for second wave

COVID's second wave looks either imminent, or is already starting to hit in many jurisdictions. Wave one saw lockdowns and closures - and not all closures were temporary. Will wave two be any different? HBI has been talking to operators across EMEA to see if forewarned is forearmed, how they predict the next few months will go, and what lessons have been learned.

Eugin process enters second-round – but will COVID impact valuation?

Sell-side advisors Perella Weinburg have shortlisted a dozen second-rounder bidders for Eugin, the global IVF arm of NMC Health, according to reports in Spain. A source tells HBI Eugin's recent figures have been significantly impacted by COVID - will it impact the valuation?

Employee testing drives 30%+ organic growth for labs through summer

COVID-19 testing for businesses, the sports industry and governments has cancelled-out and countered most falls in routine testing for the pan-European lab groups. Synlab says it signed 3,000 back-to-work testing contracts and saw 32% y-o-y organic revenue growth in June while Eurofins has 1,200 signed or in discussion. HBI examines the impact of the pandemic so far and what's next.

Optegra sales process begins

Multiple sources tell HBI that UK, Czechia and Poland-based ophthalmology platform Optegra is for sale. We take a look at the detailed figures behind the prospective sale, speculate as to price and buyers, and speak to an operator source about his view of the business.

IK Investments to sell Colisée to EQT Infrastructure

French nursing home operator Colisée is changing hands as IK Investments sells its majority stake to Sweden-based PE firm EQT's infrastructure arm. This is the first large transaction the sector has seen all year.

Rede d’Or hires banks for $2.7bn IPO

Rede d'Or, Brazil's largest hospital chain by revenue, has reportedly hired banks to prepare a long-awaited $2.7bn IPO for the autumn. The company reportedly expects a valuation of $17.8bn, which would make it the second-largest listed hospital group in the world by market capitalisation after HCA.

Bergman to re-launch sale process

Dutch and Nordic ambulatory and ophthalmology clinic chain Bergman Clinics will soon be back on the market after COVID delayed a process which began earlier this year, multiple sources tell HBI. We look at the facts and figures behind the prospective sale, and speculate on multiple and price. We are told it targeted the rest of Capio Germany from Ramsay Sante before the pandemic.

Orpea kickstarts €1.5bn propco sell-off with Icade deal

Europe's largest elderly care operator Orpea is preparing to strike more sale-and-leaseback deals with big REITs after concluding a €145m deal with Icade in Germany. HBI expects a flurry of deals may follow as part of a £1.5bn propco sell-off which will fuel further acquisitions. We talk to property investment sources about where else it might sell, potential buyers and the yields they can expect.

Find Us